Articles tagged “July 2026”
2 articles
How to Submit a Public Comment to the FDA Before July 9 (Step-by-Step)
The FDA's public comment period for the July 2026 PCAC meeting closes July 9. Here's exactly how to submit a comment on docket FDA-2025-N-6895 — and what to say if you're a patient, clinician, or researcher.
May 1, 20269 min readregulatory
The July 2026 PCAC Meeting: What's at Stake for BPC-157, TB-500, Semax, and More
On July 23–24, 2026, the FDA's Pharmacy Compounding Advisory Committee will decide whether seven peptides — including BPC-157 and TB-500 — get formally authorized for compounding. Here's what the process looks like, what outcomes are possible, and what it means for patients and clinicians.
April 19, 20267 min readregulatory
All Tags
503A503BAOD-9604BDNFBPC-157BremelanotideCJC-1295COACategory 1Category 2DihexaEgriftaEmideltideEpitalonEpithalonFDAFSAGHK-CuGHRHGIPGLP-1HPLCHSAHims & HersIpamorelinJuly 2026KPVLL-37MOTS-cMOTs-cMedicareMounjaroOzempicPCACPT-141RetatrutideRussiaSelankSemaxTB-500TesamorelinThymosin Alpha-1agingalpha-MSHanalysisanalytical chemistryangiotensin IVanti-aginganti-inflammatoryantimicrobial peptideanxiolyticbacteriostatic waterbeginnerbeginner guidebiohackingbloodworkbudgetcathelicidinclinicclinicscognitivecognitive enhancementcomparisoncompetitioncompoundingcompounding pharmacyconsultationcostcoveragedatadosingeconomicsexercisefakefertilityfinding a doctorfunctional medicineglucagongrowth hormonegut healthhealinghistoryhormoneshow toinjectioninnate immunityinsulin sensitivityinsuranceipamorelinlegallegal risklegitimatelipodystrophymarketmelanocortinmenopausemetabolismmitochondriamitochondrial peptideneuroprotectionnootropicpatient advocacypeptide guidepeptide protocolspharmaceutical-gradepharmacyphysicianpineal glandpricingprior authorizationprotocolspublic commentpurityqualityreclassificationreconstitutionrecoveryred flagsregulationregulatoryresearchretatrutidesafetysemaglutidesermorelinsexual dysfunctionside effectsstackingstoragetelehealthtelomerasetirzepatidetriple agonisttuftsinvaluevendor verificationvisceral fatweight losswhat iswomen